Association of estradiol and HPV/HPV16 infection with the occurrence of cervical squamous cell carcinoma

• Published in: Oncology letters Vol. 17; no. 3; pp. 3548 - 3554
• Main Authors: Ding, Ling, Liu, Chunliang, Zhou, Qin, Feng, Meijuan, Wang, Jintao
• Format: Journal Article
• Language: English
• Published: Greece Spandidos Publications 01.03.2019; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Associations; Carcinoma; Cervical cancer; Complications and side effects; Confidence intervals; Deoxyribonucleic acid; DNA; Enzyme-linked immunosorbent assay; Enzymes; Estradiol; Estrogens; Genetic aspects; Health aspects; Health risk assessment; Hormones; Human papillomavirus; Infection; Infections; Marital status; Marriage; Menopause; Menstruation; Oncology; Papillomavirus; Papillomavirus infections; Phenols (Class of compounds); Physiological aspects; Polymerase chain reaction; Questionnaires; Risk factors; Sex hormones; Squamous cell carcinoma; Women's health; China; uterine cervix squamous cell carcinoma; human papillomavirus; additive interaction pattern; estradiol
• ISSN: 1792-1074; 1792-1082
• DOI: 10.3892/ol.2019.10005

The associations between human papillomavirus (HPV) infection or hormonal exposure and cervical cancer risk are well established. However, to the best of our knowledge, the association between high endogenous estradiol levels in conjunction with HPV/HPV16 infection and the risk of cervical squamous cell carcinoma remains unknown. To investigate this, the current study conducted a matched case-control study in Shanxi Province, China, in which clinical samples were obtained from 74 females with newly diagnosed uterine cervix squamous cell carcinoma and 74 matched healthy females who were selected from 582 healthy females according to age, place of residence, marital status and menopausal status. From all participants, DNA was extracted from cells obtained from a cervical smear and serum was separated from venous blood withdrawn during days 5-8 of the menstrual cycle. HPV/HPV16 DNA and estradiol expression levels in the serum were measured by general polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. Significant differences were identified in the positive HPV and HPV16 DNA expression rates between patients and controls, with odds ratios (95% confidence interval) of 3.74 (1.84-7.59) and 4.04 (1.97-8.28), respectively. Expression levels of estradiol in patients were significantly higher compared with the controls (P<0.001), however, this was only identified when the HPV16 E2 or E6 oncogene status was negative. Considering 40 ng/ml as the cut-off estradiol level, 78.38% of patients exhibited high estradiol levels, which was significantly higher than the percentage of controls (P<0.001). An additive interaction pattern was revealed between estradiol expression levels and HPV/HPV16 infection. The results suggest that among the various types of HPV, HPV16 may be most likely to cause uterine cervix squamous cell carcinoma and an abnormally high level of endogenous estradiol may further increase this risk. Therefore, estradiol therapy may represent a new treatment strategy for cases of cervical cancer associated with HPV infection.